Literature DB >> 17925648

The impact of a legislative intervention to reduce tap water scald burns in an urban community.

Nicole E Leahy1, Philip J Hyden, Palmer Q Bessey, Angela Rabbitts, Nicholas Freudenberg, Roger W Yurt.   

Abstract

To review the efficacy municipal legislation in the reduction of tap water scald burns among an urban population. A retrospective chart and database review of patients hospitalized at this burn center between July 1999 and June 2004 for treatment of tap water scalds were performed. Demographic information and injury details, including extent of injury and age, type and location of the dwelling in which the injury occurred, were reviewed. Citywide incidence of these injuries for periods before and after a local prevention law was enacted was also calculated. Hospital costs for acute care treatment of these injuries were estimated. Tap water scalds increased from 15 to 22 per million/yr after legislation enactment. This burn center treated 281 of these patients during 5 years of the study period. Patients experienced significant morbidity and mortality. All cases (100%) occurred in structures exempt from current legislation. Citywide treatment costs were estimated between $102 and $148,000,000. In New York City, tap water scald burns remain a significant public health risk and continue to occur within buildings exempt from current law. Future injuries may potentially be prevented by expanding the law to include all residential buildings, regardless of building age or minimum occupancy.

Entities:  

Mesh:

Year:  2007        PMID: 17925648     DOI: 10.1097/BCR.0b013e3181599b3b

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  1 in total

1.  Still too hot: examination of water temperature and water heater characteristics 24 years after manufacturers adopt voluntary temperature setting.

Authors:  Wendy C Shields; Eileen McDonald; Shannon Frattaroli; Elise C Perry; Jeffrey Zhu; Andrea C Gielen
Journal:  J Burn Care Res       Date:  2013 Mar-Apr       Impact factor: 1.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.